AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
- Posted on March 27, 2026
- By CNBC
- 4 Views
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
